NANO MRNAの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2015/08/28 | 931 | 969 | 928 | 958 | +42 | +4.6% | 399,900 |
2015/08/27 | 890 | 916 | 880 | 916 | +57 | +6.6% | 520,800 |
2015/08/26 | 821 | 865 | 821 | 859 | +35 | +4.2% | 807,900 |
2015/08/25 | 750 | 905 | 720 | 824 | -15 | -1.8% | 1,071,400 |
2015/08/24 | 930 | 964 | 839 | 839 | -150 | -15.2% | 930,600 |
2015/08/21 | 1,000 | 1,012 | 989 | 989 | -44 | -4.3% | 451,600 |
2015/08/20 | 1,031 | 1,057 | 1,031 | 1,033 | -7 | -0.7% | 155,600 |
2015/08/19 | 1,069 | 1,075 | 1,038 | 1,040 | -34 | -3.2% | 145,700 |
2015/08/18 | 1,031 | 1,081 | 1,030 | 1,074 | +36 | +3.5% | 271,000 |
2015/08/17 | 1,033 | 1,051 | 1,033 | 1,038 | -12 | -1.1% | 143,200 |
2015/08/14 | 1,045 | 1,055 | 1,036 | 1,050 | ±0 | ±0% | 157,800 |
2015/08/13 | 1,089 | 1,089 | 1,046 | 1,050 | -36 | -3.3% | 252,400 |
2015/08/12 | 1,107 | 1,107 | 1,075 | 1,086 | -17 | -1.5% | 217,500 |
2015/08/11 | 1,107 | 1,114 | 1,100 | 1,103 | -11 | -1% | 156,300 |
2015/08/10 | 1,103 | 1,116 | 1,090 | 1,114 | +16 | +1.5% | 235,900 |
2015/08/07 | 1,100 | 1,109 | 1,080 | 1,098 | -7 | -0.6% | 380,700 |
2015/08/06 | 1,111 | 1,121 | 1,105 | 1,105 | -10 | -0.9% | 128,100 |
2015/08/05 | 1,117 | 1,125 | 1,113 | 1,115 | -13 | -1.2% | 97,200 |
2015/08/04 | 1,132 | 1,135 | 1,110 | 1,128 | -4 | -0.4% | 200,700 |
2015/08/03 | 1,149 | 1,157 | 1,128 | 1,132 | -24 | -2.1% | 126,300 |
2015/07/31 | 1,146 | 1,156 | 1,145 | 1,156 | +11 | +1% | 97,000 |
2015/07/30 | 1,146 | 1,155 | 1,141 | 1,145 | +3 | +0.3% | 94,900 |
2015/07/29 | 1,160 | 1,161 | 1,140 | 1,142 | -15 | -1.3% | 209,200 |
2015/07/28 | 1,174 | 1,193 | 1,157 | 1,157 | -3 | -0.3% | 531,900 |
2015/07/27 | 1,173 | 1,181 | 1,158 | 1,160 | -20 | -1.7% | 161,500 |
2015/07/24 | 1,162 | 1,181 | 1,155 | 1,180 | +16 | +1.4% | 201,100 |
2015/07/23 | 1,167 | 1,180 | 1,162 | 1,164 | -3 | -0.3% | 145,600 |
2015/07/22 | 1,150 | 1,170 | 1,148 | 1,167 | +4 | +0.3% | 119,700 |
2015/07/21 | 1,177 | 1,180 | 1,160 | 1,163 | +16 | +1.4% | 348,800 |
2015/07/17 | 1,142 | 1,147 | 1,129 | 1,147 | +19 | +1.7% | 124,100 |
2015/07/16 | 1,142 | 1,150 | 1,111 | 1,128 | -15 | -1.3% | 195,100 |
2015/07/15 | 1,140 | 1,166 | 1,140 | 1,143 | -13 | -1.1% | 136,900 |
2015/07/14 | 1,116 | 1,159 | 1,114 | 1,156 | +47 | +4.2% | 283,100 |
2015/07/13 | 1,110 | 1,122 | 1,104 | 1,109 | +7 | +0.6% | 113,800 |
2015/07/10 | 1,139 | 1,139 | 1,098 | 1,102 | -37 | -3.2% | 194,400 |
2015/07/09 | 1,082 | 1,149 | 971 | 1,139 | -3 | -0.3% | 676,200 |
2015/07/08 | 1,165 | 1,169 | 1,123 | 1,142 | -25 | -2.1% | 369,600 |
2015/07/07 | 1,166 | 1,177 | 1,162 | 1,167 | +10 | +0.9% | 100,700 |
2015/07/06 | 1,165 | 1,179 | 1,153 | 1,157 | -26 | -2.2% | 220,700 |
2015/07/03 | 1,180 | 1,185 | 1,171 | 1,183 | -4 | -0.3% | 141,000 |
2015/07/02 | 1,185 | 1,192 | 1,178 | 1,187 | +2 | +0.2% | 140,400 |
2015/07/01 | 1,177 | 1,186 | 1,167 | 1,185 | +14 | +1.2% | 212,800 |
2015/06/30 | 1,179 | 1,193 | 1,171 | 1,171 | -18 | -1.5% | 268,700 |
2015/06/29 | 1,168 | 1,189 | 1,164 | 1,189 | -10 | -0.8% | 367,000 |
2015/06/26 | 1,186 | 1,201 | 1,170 | 1,199 | +12 | +1% | 376,100 |
2015/06/25 | 1,199 | 1,200 | 1,187 | 1,187 | -17 | -1.4% | 274,800 |
2015/06/24 | 1,213 | 1,222 | 1,204 | 1,204 | -2 | -0.2% | 212,700 |
2015/06/23 | 1,220 | 1,230 | 1,205 | 1,206 | -12 | -1% | 236,300 |
2015/06/22 | 1,229 | 1,239 | 1,215 | 1,218 | +3 | +0.2% | 276,600 |
2015/06/19 | 1,260 | 1,261 | 1,203 | 1,215 | -25 | -2% | 573,700 |
2401~
2450
件表示中 / 3730件
類似銘柄と比較する
現在ご覧いただいている「NANO」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
NANO | 13,900円 | -30.6% | - | 0.00% | - | 3.60倍 |
|
mRNA医薬品に特化した創薬ベンチャー。創薬シーズ発掘から臨床開発まで手がけて導出 |
カイオム | 15,200円 | +92.3% | - | 0.00% | - | 5.42倍 |
|
独自の抗体作製技術を持つ理研発の創薬ベンチャー。医薬品候補抗体導出と技術供与が収益源 |
坪田ラボ | 39,600円 | +3.2% | -21.7% | 0.00% | 67.69倍 | 6.40倍 |
|
近視進行抑制、脳活性化などに強いバイオベンチャー。企業との早期契約による収益化で実績 |
メディシノバ | 19,000円 | - | - | - | - | - |
|
- |
ソレイジア | 4,000円 | +311.4% | - | 0.00% | - | 7.68倍 |
|
がん柱の創薬ベンチャー。候補品導入後に開発進め権利再導出、製品販売を行うビジネスモデル |
市場注目の銘柄
チャート関連のコラム